Prevention of Red Cell Dehydration: A Possible New Treatment for Sickle Cell Disease

References

• Bunn H F. Pathogenesis and treatment of sickle cell disease. N Engl J Med 1997; 337: 762–769
   PubMed Web of Science ®Google Scholar
• Eaton W A, Hofrichter J. Hemoglobin S gelation and sickle cell disease. Blood 1987; 70: 1245–1266
   PubMed Web of Science ®Google Scholar
• Platt O S, Orkin S H, Dover G, Beardsley G P, Miller B, Nathan D G. Hydroxy-urea enhances fetal hemoglobin production in sickle cell anemia. J Clin Invest 1984; 74: 652–656
   PubMed Web of Science ®Google Scholar
• Orringer E P, Blythe D S, Johnson A E, Phillips G, Jr., Dover G J, Parker J C. Effects of hydroxyurea on hemoglobin F and water content in the red blood cells of dogs and of patients with sickle cell anemia. Blood 1991; 78: 212–216
   PubMedGoogle Scholar
• Charache S, Dover G J, Moore R D, et al. Hydroxyurea: effects on hemoglobin F production in patients with sickle cell anemia [see comments]. Blood 1992; 79: 2555–2565
   PubMed Web of Science ®Google Scholar
• Charache S, Terrin M L, Moore R D, et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. N Engl J Med 1995; 332: 1317–1322
   PubMed Web of Science ®Google Scholar
• Scott J P, Hillery C A, Brown E R, Misiewicz V, Labotka R J. Hydroxyurea therapy in children severely affected with sickle cell disease. J Pediatr 1996; 128: 820–828
   PubMed Web of Science ®Google Scholar
• Kinney T R, Helms R W, O'Branski E E, et al. Safety of hydroxyurea in children with sickle cell anemia: results of the HUG-KIDS study, a phase I/II trial. Pediatric Hydroxyurea Group. Blood 1999; 94: 1550–1554
   PubMed Web of Science ®Google Scholar
• Bunn H F. Induction of fetal hemoglobin in sickle cell disease. Blood 1999; 93: 1787–1789
   PubMedGoogle Scholar
• Rosa R M, Bierer B E, Thomas R, et al. A study of induced hyponatremia in the prevention and treatment of sickle-cell crisis. N Engl J Med 1980; 303: 1138–1143
   PubMed Web of Science ®Google Scholar
• Clark M R, Unger R C, Shohet S B. Monovalent cation composition and ATP and lipid content of irreversibly sickled cells. Blood 1978; 51: 1169–1178
   Google Scholar
• Bertles J F, Milner P FA. Irreversibly sickled erythrocytes: a consequence of the heterogeneous distribution of hemoglobin types in sickle cell anemia. J Clin Invest 1968; 47: 1731–1741
   PubMed Web of Science ®Google Scholar
• Billett H H, Kim K, Fabry M E, Nagel R L. The percentage of dense red cells does not predict incidence of sickle cell painful crisis. Blood 1986; 68: 301–303
   PubMed Web of Science ®Google Scholar
• Serjeant G R, Serjeant B E, Milner P F. The irreversibly sickled cell; a determinant of hemolysis in sickle cell anemia. Br J Haematol 1969; 17: 527–533
   PubMed Web of Science ®Google Scholar
• Fabry M E, Mears J G, Patel P, et al. Dense cells in sickle cell anemia: the effects of gene interaction. Blood 1984; 64: 1042–1046
   PubMed Web of Science ®Google Scholar
• Horiuchi K, Stephens M J, Adachi K, Asakura T, Schwartz E, Ohene-Frempong K. Image analysis studies of the degree of irreversible deformation of sickle cells in relation to cell density and Hb F level. BrJ Haematol 1993; 85: 356–364
   Google Scholar
• Ballas S K, Smith E D. Red blood cell changes during the evolution of the sickle cell painful crisis. Blood 1992; 79: 2154–2163
   PubMed Web of Science ®Google Scholar
• Lawrence C, Fabry M E, Nagel R L. Red cell distribution width parallels dense red cell disappearance during painful crises in sickle cell anemia. J Lab Clin Med 1985; 105: 706–710
   PubMedGoogle Scholar
• Kaul D K, Chen D, Zhan J. Adhesion of sickle cells to vascular endothclium is critically dependent on changes in density and shape of the cells. Blood 1994; 83: 3006–3017
   PubMed Web of Science ®Google Scholar
• Kaul D K, Fabry M E, Nagel R L. Vasoocclusion by sickle cells: evidence for selective trapping of dense red cells. Blood 1986; 68: 1162–1166
   PubMed Web of Science ®Google Scholar
• Kaul D K, Fabry M E, Windisch P, Baez S, Nagel R L. Erythrocytes in sickle cell anemia are heterogeneous in their rheological and hemodynamic characteristics. J Clin Invest 1983; 72: 22–31
   PubMed Web of Science ®Google Scholar
• Joiner C H. Cation transport and volume regulation in sickle red blood cells. Am J Physiol 1993; 264: C251–770
   PubMedGoogle Scholar
• Lew V L, Hockaday A, Sepulveda M I, et al. Compartmentalization of sickle-cell calcium in endocytic inside-out vesicles. Nature 1985; 315: 586–589
   PubMed Web of Science ®Google Scholar
• Bookchin R M, Ortiz O E, Lew V L. Evidence for a direct reticulocyte origin of dense red cells in sickle cell anemia. J Clin Invest 1991; 87: 113–124
   PubMed Web of Science ®Google Scholar
• Gardos G. The function of calcium in the potassium permeability of human erythrocytes. Biochim Biophys Acta 1958; 30: 653–654
   PubMed Web of Science ®Google Scholar
• Brugnara C, Armsby C C, De Franceschi L, Crest M, Euclaire M F, Alper S L. Ca(2 +)-activated K+ channels of human and rabbit erythrocytes display distinctive patterns of inhibition by venom peptide toxins. J Mem Biol 1995; 147: 71–82
   Google Scholar
• De Franceschi L, Brugnara C, Rouyer-Fessard P, Jouault H, Beuzard Y. Formation of dense erythrocytes in SAD mice exposed to chronic hypoxia: evaluation of different therapeutic regimens and of a combination of oral clotrimazole and magnesium therapies. Blood 1999; 94: 4307–4313
   PubMed Web of Science ®Google Scholar
• Brugnara C, Kopin A. K., Bunn H F, Tosteson D C. Regulation of cation content and cell volume in erythrocytes from patients with homozygous hemoglobin C disease. J Clin Invest 1985; 75: 1608–1617
   PubMed Web of Science ®Google Scholar
• Brugnara C, Tosteson D C. Cell volume, K transport, and cell density in human erythrocytes. Am J Physiol 1987; 252: C269–276
   Google Scholar
• Brugnara C, Bunn H F, Tosteson D C. Regulation of erythrocyte cation and water content in sickle cell anemia. Science 1986; 232: 388–390
   PubMed Web of Science ®Google Scholar
• Canessa M, Fabry M E, Spalvins A, Blumenfeld N, Nagel R L. Activation of a K:C1 cotransporter by cell swelling in HbAA and HbSS red cells. Prog Clin Biol Res 1987; 240: 201–215
   Google Scholar
• Ballas S K, Larner J, Smith E D, Surrey S, Schwartz E, Rappaport E F. The xerocytosis of SC disease. Blood 1987; 69: 124–130
   PubMedGoogle Scholar
• Lawrence C, Fabry M E, Nagel R L. The unique red cell heterogeneity of SC disease: crystal formation, dense reticulocytes, and unusual morphology. Blood 1991; 78: 2104–2112
   PubMedGoogle Scholar
• Canessa M, Romero J R, Lawrence C, Nagel R L, Fabry M E. Rate of activation and deactivation of K: Cl cotransport by changes in cell volume in hemoglobin SS, CC and AA red cells. J Mem Biol 1994; 142: 349–362
   Google Scholar
• Olivieri O, De Franceschi L, Capellini M D, Girelli D, Corrocher R, Brugnara C. Oxidative damage and erythrocyte membrane transport abnormalities in thalassemias. Blood 1994; 84: 315–320
   PubMed Web of Science ®Google Scholar
• De Franceschi L, Fumagalli L, Olivieri O, Corrocher R, Lowell C A, Berton G. Deficiency of src family kinases Fgr and Hck results in activation of erythrocyte K/Cl cotransport. J Clin Invest 1997; 99: 220–227
   PubMed Web of Science ®Google Scholar
• Jennings M L, Schulz R K. Okadaic acid inhibition of K-Cl cotransport. J Gen Physiol 1991; 97: 799–818
   PubMed Web of Science ®Google Scholar
• Bize I, Munoz P, Canessa M, Dunham P B. Stimulation of membrane serine-threonine phosphatase in erythrocytes by hydrogen peroxide and staurosporine. Am J Physiol 1998; 274: C440–446
   Google Scholar
• Bize BGv I, Robb A, Buchbinder G, Brugnara C. Serine/threonine protein phosphatases and regulation of K-Cl cotransport in human erythrocytes. Am J Physiol 1999; 277: C926–C936
   Google Scholar
• Brugnara C, Van Ha T, Tosteson D C. Acid pH induces formation of dense cells in sickle erythrocytes. Blood 1989; 74: 487–495
   PubMed Web of Science ®Google Scholar
• Franco R S, Palascak M, Thompson H, Joiner C H. KCl cotransport activity in light versus dense transferrin receptor-positive sickle reticulocytes. J Clin Invest 1995; 95: 2573–2580
   PubMedGoogle Scholar
• Brugnara C, Tosteson D C. Inhibition of K transport by divalent cations in sickle erythrocytes. Blood 1987; 70: 1810–1815
   PubMed Web of Science ®Google Scholar
• Canessa M, Fabry M E, Nagel R L. Deoxygenation inhibits the volume-stimulated, Cl(—)-dependent K+ efflux in SS and young AA cells: a cytosolic Mg2+ modulation. Blood 1987; 70: 1861–1866
   Google Scholar
• Tosteson D C, Shea E, Darling R C. Potassium and sodium of red blood cells in sickle cell anemia. J Clin Invest 1952; 31: 406–411
   PubMed Web of Science ®Google Scholar
• Joiner C H, Dew A, Ge D L. Deoxygenation-induced cation fluxes in sickle cells: relationship between net potassium efflux and net sodium influx. Blood Cells 1988; 13: 339–358
   PubMedGoogle Scholar
• Berkowitz L R, Orringer E P. Passive sodium and potassium movements in sickle erythrocytes. Am J Physiol 1985; 249: C208–C214, (Cell Physiol 18)
   Google Scholar
• Joiner C H. Deoxygenation-induced cation fluxes in sickle cells: II. Inhibition by stilbene disulfonates. Blood 1990; 76: 212–220
   PubMed Web of Science ®Google Scholar
• Joiner C H, Platt O S, Lux S ET. Cation depletion by the sodium pump in red cells with pathologic cation leaks. Sickle cells and xerocytes. J Clin Invest 1986; 78: 1487–1496
   PubMed Web of Science ®Google Scholar
• Joiner C H, Claussen W, Yasin Z, Franco R S. Dipyridamole inhibits in vitro deoxygenation-induced cation fluxes in sickle cell red blood cells at membrane concentrations achievable in blood. Blood 1997; 90: 125, (a)
   Web of Science ®Google Scholar
• Hebbel R P. Membrane-associated iron. Sickle Cell Disease: Basic Principles and Clinical Practice, S H Embury, R P Hebbel, N Mohandas, M H Steinberg. Raven Press, Ltd, New York 1994; 163–172
   Google Scholar
• Hebbel R P, Mohandas N. Reversible deformation-dependent erythrocyte cation leak. Extreme sensitivity conferred by minimal peroxidation. Biophys J 1991; 60: 712–715
   Google Scholar
• Sugihara T, Hebbel R P. Exaggerated cation leak from oxygenated sickle red blood cells during deformation: evidence for a unique leak pathway. Blood 1992; 80: 2374–2378
   Google Scholar
• Shalev O, Repka T, Goldfarb A, et al. Deferiprone (Ll) chelates pathologic iron deposits from membranes of intact thalassemic and sickle red blood cells both in vitro and in vivo. Blood 1995; 86: 2008–2013
   PubMed Web of Science ®Google Scholar
• Alvarez J, Montero M, Garcia-Sancho J. High affinity inhibition of Ca2 + -dependent K+ channels by cytochrome P-450 inhibitors. J Biol Chem 1992; 267: 11789–11793
   PubMed Web of Science ®Google Scholar
• Weuta H. Clinical studies with oral clotrimazole. Postgrad Med J 1974; 50(Suppl 1)45–48
   Google Scholar
• Sawyer P R, Brogden R N, Pinder R M, Speight T M, Avery G S. Clotrimazole: a review of its antifungal activity and therapeutic efficacy. Drugs 1975; 9: 424–447
   PubMed Web of Science ®Google Scholar
• Seo M, Iida H, Miura Y. Basic experiments with clotrimazole administered orally. Curr Med Res Opin 1977; 5: 169–178
   PubMed Web of Science ®Google Scholar
• Tettenborn D. Toxicity of clotrimazole. Postgrad Med J 1974; 50(Suppl 1)17–20
   Google Scholar
• Brugnara C, de Franceschi L, Alper S L. Inhibition of Ca(2 +)-dependent K + transport and cell dehydration in sickle erythrocytes by clotrimazole and other imidazole derivatives. J Clin Invest 1993; 92: 520–526
   PubMed Web of Science ®Google Scholar
• De Franceschi L, Saadane N, Trudel M, Alper S L, Brugnara C, Beuzard Y. Treatment with oral clotrimazole blocks Ca(2 +)-activated K+ transport and reverses erythrocyte dehydration in transgenic SAD mice. A model for therapy of sickle cell disease. J Clin Invest 1994; 93: 1670–1676
   PubMed Web of Science ®Google Scholar
• Brugnara C, Armsby C C, Sakamoto M, Rifai N, Alper S L, Platt O. Oral administration of clotrimazole and blockade of human erythrocyte Ca++-activated K+ channel: the imidazole ring is not required for inhibitory activity. J Pharmacol Exp Ther 1995; 273: 266–272
   PubMed Web of Science ®Google Scholar
• Rifai N, Sakamoto M, Law T, et al. HPLC measurement, blood distribution, and pharmacokinetics of oral clotrimazole, potentially useful antisickling agent. Clin Chem 1995; 41: 387–391
   Google Scholar
• Matsuura Y, Kotani E, Iio T, et al. Structure-activity relationships in the induction of hepatic microsomal cytochrome P450 by clotrimazole and its structurally related compounds in rats. Biochem Pharmacol 1991; 41: 1949–1956
   Google Scholar
• Brugnara C, Gee B, Armsby C C, et al. Therapy with oral clotrimazole induces inhibition of the Gardos channel and reduction of erythrocyte dehydration in patients with sickle cell disease. J Clin Invest 1996; 97: 1227–1234
   PubMed Web of Science ®Google Scholar
• Johnson C S, Omata M, Tong M J, Simmons J F, Jr., Weiner J, Tatter D. Liver involvement in sickle cell disease. Medicine (Baltimore) 1985; 64: 349–356
   PubMed Web of Science ®Google Scholar
• Schubert T T. Hepatobiliary system in sickle cell disease. Gastroenterology 1986; 90: 2013–2021
   PubMed Web of Science ®Google Scholar
• Brugnara C, Armsby C C, Sakamoto M, Rifai N, Alper S L, Platt O. Oral administration of clotrimazole and blockade of human erythrocyte Ca(+ +)-activated K+ channel: the imidazole ring is not required for inhibitory activity. J Pharmacol Exp Therap 1995; 273: 266–272
   PubMed Web of Science ®Google Scholar
• De Franceschi L, Beuzard Y, Jouault H, Brugnara C. Modulation of erythrocyte potassium chloride cotransport, potassium content, and density by dietary magnesium intake in transgenic SAD mouse. Blood 1996; 88: 2738–2744
   PubMed Web of Science ®Google Scholar
• De Franceschi L, Bachir D, Galacteros F, et al. Oral magnesium supplements reduce erythrocyte dehydration in patients with sickle cell disease. J Clin Invest 1997; 100: 1847–1852
   PubMed Web of Science ®Google Scholar
• De Franceschi L, Bachir D, Galacteros F, et al. Dietary magnesium supplementation reduces pain crises in patients with sickle cell disease. ASH. W. B. Saunders Company, San Diego, CA 1997
   Google Scholar